Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
venture capital (VC)
Biotech
2 ex-Moderna leaders unveil $325M inaugural VC fund
The Florida-based firm backs companies that tout multiple-medicine platforms and are in the earlier phases of human studies.
Gabrielle Masson
Oct 9, 2025 3:09pm
Fierce Biotech Fundraising Tracker: Expedition, Arthrosi & more
Oct 9, 2025 11:22am
Arthrosi raises $153M, fueling dash toward phase 3 gout data
Oct 8, 2025 10:15am
TCG Crossover hauls in $1.3B for 3rd investment fund
Oct 6, 2025 11:14am
Sparrow flits forward with $95M for midstage diabetes asset
Sep 24, 2025 11:22am
Sanofi juices up venture arm with $625M infusion
Sep 24, 2025 1:00am
